Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Tandem Diabetes Care (TNDM) has a market cap of $1.18 billion USD. According to our data, Tandem Diabetes Care is ranked No.4770 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.18 B |
-50.17%
|
| Dec 31, 2024 | $2.37 B |
21.77%
|
| Dec 29, 2023 | $1.94 B |
-34.19%
|
| Dec 30, 2022 | $2.95 B |
-70.14%
|
| Dec 31, 2021 | $9.89 B |
57.32%
|
| Dec 31, 2020 | $6.28 B |
60.51%
|
| Dec 31, 2019 | $3.91 B |
56.99%
|
| Dec 31, 2018 | $2.49 B |
1,508.90%
|
| Dec 29, 2017 | $0.15 B |
-89.02%
|
| Dec 30, 2016 | $1.41 B |
-81.80%
|
| Dec 31, 2015 | $7.76 B |
-7.01%
|
| Dec 31, 2014 | $8.34 B |
-50.72%
|
| Dec 31, 2013 | $16.92 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Medtronic
MDT
|
$105.64 B |
0.002 M
|
Ireland
|
 Insulet
PODD
|
$18.01 B |
0.000 M
|
USA
|
 DexCom
DXCM
|
$27.15 B |
0.001 M
|
USA
|
 Abbott Laboratories
ABT
|
$218.91 B |
-0.002 M
|
USA
|
 Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
Denmark
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Senseonics Holdings
SENS
|
$0.40 B |
0.000 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Becton Dickinson
BDX
|
$58.01 B |
-0.001 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
| Market Cap | = | TNDM Stock Price | * | TNDM Shares Outstanding |
| = | $17.71 | * | 66.56 M | |
| = | $1.18 B |